Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
High-Resolution Biophysical Analysis of LNP Structure and Fu
2026-05-30
This reference study applies advanced, label-free biophysical techniques to characterize the structural and functional properties of lipid nanoparticles (LNPs) used for mRNA delivery. By resolving key limitations of traditional LNP characterization methods, the work establishes how heterogeneity in LNP size, RNA loading, and shape impacts delivery efficiency, providing actionable insights to improve nanoparticle formulation and gene regulation studies.
-
Biotin-HPDP in Thiol-Specific Protein Labeling: Protocols &
2026-05-29
Biotin-HPDP empowers selective, reversible thiol labeling for advanced redox proteomics, enabling affinity purification and dynamic PTM mapping in neurodegeneration research. This article bridges recent workflow innovations and troubleshooting tactics for maximizing sensitivity, reproducibility, and specificity using APExBIO’s Biotin-HPDP.
-
Calpain Inhibitor I, ALLN: Practical Parameters for Research
2026-05-29
Calpain Inhibitor I, ALLN provides selective inhibition of calpain and cathepsin proteases, enabling precise control in apoptosis assays and ischemia-reperfusion injury models. It is intended solely for laboratory research workflows and is not suitable for diagnostic or therapeutic use.
-
Antimycin A4: ATP-Citrate Lyase Inhibitor for Metabolic Rese
2026-05-28
Antimycin A4 is a dual-action ATP-citrate lyase inhibitor and mitochondrial respiratory chain blocker, offering unique leverage for dissecting cellular energy and lipid biosynthesis. This article outlines practical workflows, troubleshooting, and comparative advantages for using Antimycin A4 in metabolic and mitochondrial research.
-
HyperScript™ Reverse Transcriptase: Advancing RNA-Seq and qP
2026-05-28
Discover how HyperScript™ Reverse Transcriptase empowers high-fidelity cDNA synthesis for qPCR and RNA-Seq, especially for complex or low-abundance RNA. This article explains the science behind its engineering and highlights practical assay choices for cutting-edge transcriptomics.
-
Methyl-β-cyclodextrin: Technical Use in Membrane Cholesterol
2026-05-27
Methyl-β-cyclodextrin is used to selectively extract cholesterol and modulate membrane organization in cell-based and biochemical assays. It should be deployed where precise, reproducible manipulation of membrane cholesterol or lipid raft structure is required, but is not suitable for diagnostic or medical workflows.
-
AEBSF.HCl in Protease Inhibition and Amyloid Research Workfl
2026-05-27
AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) empowers researchers to dissect serine protease-driven mechanisms in cell death, amyloid-beta modulation, and lysosomal integrity. This article unpacks advanced use-cases, step-by-step protocols, and troubleshooting strategies for maximizing experimental success with AEBSF.HCl.
-
Epalrestat in Translational Research: Neuroprotection, Proto
2026-05-26
Explore how Epalrestat, a potent aldose reductase inhibitor, is transforming translational research in neurodegeneration and metabolic disease. This article integrates mechanistic insight, evidence from leading studies, and strategic guidance for deploying Epalrestat in advanced research workflows. Protocol tips, competitive context, and a nuanced outlook empower researchers to leverage Epalrestat’s dual targeting of the polyol pathway and KEAP1/Nrf2 signaling.
-
RG108 (SKU A1913): Reliable DNMT Inhibition for Epigenetic R
2026-05-26
This article addresses key laboratory challenges in epigenetic modulation, focusing on RG108 (SKU A1913) as a robust DNA methyltransferase inhibitor. Through scenario-driven Q&A, we discuss practical solutions for demethylation workflows, protocol optimization, and vendor reliability—helping researchers achieve reproducible, sensitive results with RG108.
-
Ceramide-Driven Autophagy Fuels Fish Nodavirus Replication
2026-05-25
This study reveals how red-spotted grouper nervous necrosis virus (RGNNV) manipulates host ceramide metabolism to promote viral replication through autophagy. Lipidomics profiling identifies ceramide flux as a proviral mediator, offering both mechanistic insight and potential intervention targets for controlling viral nervous necrosis.
-
LY2886721: Precision BACE Inhibitor Workflows in Alzheimer’s
2026-05-25
LY2886721 sets a new benchmark for Alzheimer’s disease research by enabling precise, dose-controlled BACE1 inhibition and robust amyloid beta reduction without compromising synaptic function. Discover streamlined workflows, protocol optimizations, and troubleshooting strategies that unlock translational insights using this nanomolar-potency inhibitor from APExBIO.
-
Neurotensin: Advanced Workflows for GPCR Trafficking Studies
2026-05-24
Neurotensin (CAS 39379-15-2) empowers precise modulation of GPCR trafficking and miRNA signaling in gastrointestinal and neural cell models. Explore robust, reproducible protocols and actionable troubleshooting tips that address spectral interference and complex assay design, all backed by APExBIO’s high-purity standards.
-
Safe DNA Gel Stain: Streamlining DNA and RNA Gel Visualizati
2026-05-23
APExBIO’s Safe DNA Gel Stain empowers molecular biologists with high-sensitivity nucleic acid detection while reducing exposure to mutagenic agents and UV damage. Its dual blue-light/UV compatibility and workflow flexibility improve cloning efficiency and data integrity, setting a new standard for safe, reproducible gel imaging.
-
circ_0042103/TAF15/NER Axis Drives DNA Damage in Pulpitis
2026-05-22
This study uncovers how the circ_0042103/TAF15/NER regulatory axis amplifies DNA damage and inflammation in dental pulp stem cells during pulpitis. By dissecting the molecular mechanisms by which circular RNA circ_0042103 modulates DNA repair and inflammatory signaling, the research advances our understanding of RNA-mediated pathology in dental disease and suggests new targets for therapeutic investigation.
-
InstaBlue Protein Stain Solution: Rapid, Sensitive Protein V
2026-05-22
InstaBlue Protein Stain Solution accelerates protein gel analysis, delivering ultra-fast, high-sensitivity Coomassie Brilliant Blue detection without toxic solvents or tedious destaining. Its unique formulation preserves protein integrity for downstream mass spectrometry, setting a new standard for biomedical research protein visualization.